DK1248650T3 - Forbedrede DNA-vacciner til bovint herpesvirus 1 - Google Patents

Forbedrede DNA-vacciner til bovint herpesvirus 1

Info

Publication number
DK1248650T3
DK1248650T3 DK01907651T DK01907651T DK1248650T3 DK 1248650 T3 DK1248650 T3 DK 1248650T3 DK 01907651 T DK01907651 T DK 01907651T DK 01907651 T DK01907651 T DK 01907651T DK 1248650 T3 DK1248650 T3 DK 1248650T3
Authority
DK
Denmark
Prior art keywords
herpes virus
dna vaccines
virus dna
bovine herpes
enhanced
Prior art date
Application number
DK01907651T
Other languages
Danish (da)
English (en)
Inventor
Laurent Bernard Fischer
Jean-Christophe Franc Audonnet
Simona Barzu-Le-Roux
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of DK1248650T3 publication Critical patent/DK1248650T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK01907651T 2000-01-21 2001-01-19 Forbedrede DNA-vacciner til bovint herpesvirus 1 DK1248650T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000798A FR2804028B1 (fr) 2000-01-21 2000-01-21 Vaccins adn ameliores pour animaux de rente
PCT/FR2001/000187 WO2001052888A2 (fr) 2000-01-21 2001-01-19 Vaccins adn ameliores pour animaux de rente

Publications (1)

Publication Number Publication Date
DK1248650T3 true DK1248650T3 (da) 2007-04-16

Family

ID=8846183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01907651T DK1248650T3 (da) 2000-01-21 2001-01-19 Forbedrede DNA-vacciner til bovint herpesvirus 1

Country Status (21)

Country Link
EP (1) EP1248650B1 (ja)
JP (1) JP2004500375A (ja)
KR (1) KR100820893B1 (ja)
CN (2) CN101554480A (ja)
AR (1) AR027926A1 (ja)
AT (1) ATE346611T1 (ja)
AU (1) AU783865B2 (ja)
BR (2) BRPI0107767B1 (ja)
CA (1) CA2398229C (ja)
CY (1) CY1107627T1 (ja)
DE (1) DE60124862T2 (ja)
DK (1) DK1248650T3 (ja)
ES (1) ES2277913T3 (ja)
FR (1) FR2804028B1 (ja)
HU (1) HU229597B1 (ja)
MX (1) MXPA02007110A (ja)
NZ (1) NZ520270A (ja)
PL (1) PL209304B1 (ja)
PT (1) PT1248650E (ja)
WO (1) WO2001052888A2 (ja)
ZA (1) ZA200205698B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
ES2429338T3 (es) 2002-12-23 2013-11-14 Vical Incorporated Vacuna basada en polinucleótidos optimizados por codones contra infección por citomegalovirus humano
WO2004073737A1 (en) * 2003-02-19 2004-09-02 Merial Limited Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
CU23544A1 (es) 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
WO2010135747A1 (en) * 2009-05-22 2010-11-25 Genocea Biosciences Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
JP2014500875A (ja) * 2010-11-19 2014-01-16 ベイジン カイン テクノロジー シェア−ホールディング シーオー．， エルティーディー． Ｂ型肝炎の予防及び治療のためのｄｎａワクチン組成物
CN112034169A (zh) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679356A (en) * 1992-07-08 1997-10-21 Schering Corporation Use of GM-CSF as a vaccine adjuvant
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
WO1996007739A2 (en) * 1994-09-09 1996-03-14 Neurocrine Biosciences, Incorporated Interleukin-1 type 3 receptors
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
EP0826063A1 (en) * 1995-04-25 1998-03-04 Vical Incorporated Single-vial formulations of dna/lipid complexes
JPH11508231A (ja) * 1995-05-26 1999-07-21 ソマティックス セラピー コーポレイション 安定な脂質／核酸複合体を含む送達ビヒクル
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
WO1998040499A1 (en) * 1997-03-10 1998-09-17 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purposes
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
CZ20014392A3 (cs) * 1999-06-10 2002-06-12 Merial Vakcína AND pro domácí a sportovní zvířata
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV

Also Published As

Publication number Publication date
HUP0203974A2 (hu) 2003-03-28
WO2001052888A3 (fr) 2001-12-20
CA2398229C (en) 2012-05-15
CN101554480A (zh) 2009-10-14
CN1404398A (zh) 2003-03-19
FR2804028A1 (fr) 2001-07-27
PL209304B1 (pl) 2011-08-31
EP1248650A2 (fr) 2002-10-16
PL356554A1 (en) 2004-06-28
ATE346611T1 (de) 2006-12-15
KR20020084093A (ko) 2002-11-04
DE60124862D1 (de) 2007-01-11
ZA200205698B (en) 2003-09-29
CY1107627T1 (el) 2013-04-18
PT1248650E (pt) 2007-02-28
ES2277913T3 (es) 2007-08-01
BR0107767A (pt) 2002-11-12
CN1404398B (zh) 2012-05-02
NZ520270A (en) 2004-08-27
HUP0203974A3 (en) 2004-07-28
EP1248650B1 (fr) 2006-11-29
CA2398229A1 (en) 2001-07-26
DE60124862T2 (de) 2007-07-05
MXPA02007110A (es) 2003-01-28
WO2001052888A2 (fr) 2001-07-26
AU783865B2 (en) 2005-12-15
AU3556601A (en) 2001-07-31
JP2004500375A (ja) 2004-01-08
BRPI0107767B1 (pt) 2017-10-24
AR027926A1 (es) 2003-04-16
HU229597B1 (en) 2014-02-28
FR2804028B1 (fr) 2004-06-04
KR100820893B1 (ko) 2008-04-10

Similar Documents

Publication Publication Date Title
CY2016020I2 (el) Στελεχη ιου του ερπη για γονιδιακη θepαπεια
DK1058558T3 (da) Rekombinante og adjuverede vacciner mod influenzavirus og herpesvirus
GB2337755B (en) Virus vaccine
NO20003302D0 (no) Vaksine
ZA975619B (en) Recombinant live vaccine based on canine herpesvirus in particular against carre's disease rabies or the para-influenza virus type 2
NO20014323D0 (no) Vaksine
DE60002650D1 (de) Öladjuvierter Impfstoff
MA25489A1 (fr) Vaccins
FR2776928B1 (fr) Vaccins adn adjuves
DK1248650T3 (da) Forbedrede DNA-vacciner til bovint herpesvirus 1
EP1204424A4 (en) VACCINES AND RECOMBINANT RS VIRUS EXPRESSION SYSTEMS
DK1372712T3 (da) Vaccine mod equint herpesvirus
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
IS6184A (is) Bóluefni gegn ISA veiru
HUP0002908A2 (en) Recombinant newcastle disease virus as embryo vaccine
EP1296710A4 (en) RECOMBINANT VACCINES AGAINST INFECTIOUS BURSITY VIRUS
AU2002347346A8 (en) Dna vaccine
SI1155119T1 (sl) Virusno cepivo z deletiranim BHV-1 genom
GB9917981D0 (en) Viral vaccine
ITMI981384A1 (it) Vaccino per hiv
GB9826647D0 (en) DNA vaccines
NO20002213L (no) Babesia vaksine
GB0118475D0 (en) Dna vaccine